期刊文献+

人分泌型磷脂酶A2(hsPLA2-IIA)基因的克隆、表达及活性鉴定

Gene Coloning,Expression and Enzymatic Assay of Human sPLA2-IIA
下载PDF
导出
摘要 目的为了构建人分泌型磷脂酶A2(secretaryphospholipaseA2,sPLA2-IIA)的有效表达系统,从胎脾中提取总RNA。方法采用RT-PCR方法扩增出编码sPLA2-IIA的基因定向地克隆于硫氧环蛋白基因融合表达载体pET32a的TrxA基因3′末端,构建符合读码框的融合表达载体pET32a-sPLA2-IIA。37℃下经IPTG诱导,hsPLA2-IIA融合蛋白在大肠杆菌BL21(DE3)中获得高效表达,表达产物以包涵体的形式存在。包涵体经8mol/L尿素溶解、复性后检测结果显示具有较高的催化活性并呈现剂量依赖关系。结论以大肠杆菌为宿主,成功表达了hsPLA2-IIA蛋白,为进一步进行hsPLA2-IIA的大量生产和功能研究奠定了基础。 Objective: To clone the cDNA of human sPLA2-ⅡA, construct the engineered Escherischia coli expressing human sPLA2-ⅡA and identify the expressed human sPLA2-ⅡA. Methods: Total RNAs were purified from human fetal spleen. The cDNA of human sPLA2-ⅡA was cloned by RT-PCR and inserted into plasmid pET32a( + ) between NcoⅠ and EcoRⅠ sites for expressing the recombinant human sPLA2-ⅡA in Escherischia coli BL21 (DE3). The recombinants were screened by SDS-PAGE. The engineered Escherischia coli expressing trxAhuman sPLA2-ⅡA fusion protein was established. The expressed human sPLA2-ⅡA exists in the form of inclusion body and accounts for about 25% of the total proteins of Escherischia coli BL21 (DE3). Conclusion: the engineered E. coli methods are suitable for preparing plenty of human sPLA2-ⅡA which has laid base for the large-scale expression, purification and basic studies of human sPLA2-ⅡA.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2006年第8期93-97,共5页 China Biotechnology
关键词 人分泌型磷脂酶A2 融合表达 酶活性鉴定 Human sPLA2-ⅡA Fusion expression Enzymatic Assay
  • 相关文献

参考文献10

  • 1Glaser K B,Asmis R,Dennis E A.Bacterial lipopolysaccharide priming of P388D1 macrophage-like cells for enhanced arachidonic acid metabolism.Platelet-activating factor receptor activation and regulation of phospholipase A2.J Biol Chem,1990,265:8658 ~8664.
  • 2Davidson F F,Dennis E A.Evolutionary relationships and implications for the regulation of phospholipase A 2 from snake venom to human secreted forms.J Mol Evol,1990,31:228 ~238.
  • 3Pruzanski W,Vadas P,Kim J,et al.Phospholipase activity associated with synovial fluid cells.J Rheumatol,1988,15:791 ~ 794.
  • 4Vadas P,Pruzanski W,Kim J,et al.The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2.Am J Pathol,1989,134:807 ~811.
  • 5Vadas P,Pruzanski W,Kim J,et al.The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2.Am J Pathol,1989,134:807 ~811.
  • 6Cloning and recmbinat expression of phospholipase A2 present in rheumatoid arthritic synovial fluid.J Biol Chem,1989,264 (10):5335 ~5338.
  • 7Attalah H L,Wu Y,Alaoui-El-Azher M,et al.Induction of type-ⅡA secretory phospholipase A2 in animal models of acute lung injury.Eur Respir J,2003,21 (6):1040 ~ 1045.
  • 8Touqui L,Alaoui-El-Azher M.Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases.Curr Mol Med,2001,1 (6):739 ~ 754.
  • 9Adriana V R,Paulo L H,Martha M,et al.Nascimento Highlevel expression of tetanus toxin fragment C-thioredoxin fusion protein in Escherichia coli.Curr Opin Biotechnol,1995,6(5):501 ~506.
  • 10Othman R,Baker S,Li Y,et al.Human non-pancreatic (group Ⅱ) secreted phospholipase A2 characterisation of Nterminal mutants.Biochim Biochem Biophys Acta,1996,1303:92 ~ 102.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部